GlassScriptPhysician profile
Philip A Meinhardt
NPI 1356592919
$507,133.16
in general payments reported to CMS, 2019-2025
21 companies · $7,729 in 2025
The $7,729 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $150K · 2021: $130K · 2022: $151K · 2023: $18K · 2024: $12K · 2025: $7,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $37K · Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $36,785.00 |
| Food and Beverage | $1,422.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kalitec Direct LLC | $502,803.62 | 2019-2025 | Intess Cervical Cage, Intess Cervical Cage |
| Nevro Corp. | $2,045.56 | 2022 | |
| Curiteva, INC. | $566.32 | 2024 | |
| Boston Scientific Corporation | $328.93 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $310.15 | 2021-2023 | Intracept |
| Medtronic USA, INC. | $240.26 | 2019-2020 | |
| Orthofix Medical, INC. | $208.11 | 2024-2025 | Spinal-Stim, Stim On Track, Cervical-Stim |
| Stryker Corporation | $123.81 | 2019-2025 | Spinejack |
| Surgalign Spine Technologies, INC. | $98.89 | 2020 | |
| Mvp Orthopedics INC | $83.32 | 2021-2022 | |
| Biocomposites INC | $53.40 | 2025 | Stimulan |
| Pacira Therapeutics, INC. | $49.13 | 2019-2020 | |
| Depuy Synthes Sales INC. | $42.73 | 2019-2022 | |
| Ethicon US, LLC | $40.02 | 2020-2023 | Stratafix, Dermabond Prineo |
| Ulrich Medical USA, INC. | $32.86 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $21.33 | 2025 | |
| Checkpoint Surgical, INC | $19.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.82 | 2020 | |
| Electronic Waveform Lab, INC. | $16.70 | 2019 | |
| Smith+Nephew, INC. | $15.86 | 2024 | Renasys Touch, Pico 14 |
| Abbott Laboratories | $14.65 | 2025 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,130,361.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Meinhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.